Literature DB >> 30905395

Pancreatic cancer surgical management.

Florence Jeune1, Romain Coriat2, Frédéric Prat2, Bertrand Dousset3, Jean-Christophe Vaillant4, Sébastien Gaujoux3.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains a dismal prognosis and surgery is the only chance for cure. However, only few of the patients have localized tumor eligible for curative complete resection. Preoperative management and well-staging of the disease are the cornerstone for appropriate surgery and major issues to define the best therapeutic strategy. This review focuses on the surgical and optimal perioperative management of PDAC and summarizes updates data on the subject.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30905395     DOI： 10.1016/j.lpm.2019.02.027

Source DB:  PubMed          Journal:  Presse Med        ISSN： 0755-4982            Impact factor:   1.228


  7 in total

Review 1.  International expert consensus on laparoscopic pancreaticoduodenectomy.

Authors:  Renyi Qin; Michael L Kendrick; Christopher L Wolfgang; Barish H Edil; Chinnusamy Palanivelu; Rowan W Parks; Yinmo Yang; Jin He; Taiping Zhang; Yiping Mou; Xianjun Yu; Bing Peng; Palanisamy Senthilnathan; Ho-Seong Han; Jae Hoon Lee; Michiaki Unno; Steven W M Olde Damink; Virinder Kumar Bansal; Pierce Chow; Tan To Cheung; Nim Choi; Yu-Wen Tien; Chengfeng Wang; Manson Fok; Xiujun Cai; Shengquan Zou; Shuyou Peng; Yupei Zhao
Journal:  Hepatobiliary Surg Nutr       Date:  2020-08       Impact factor: 7.293

2.  Dauricine suppresses the growth of pancreatic cancer in vivo by modulating the Hedgehog signaling pathway.

Authors:  Ying-Bo Zhang; Hong-Xin Fei; Jia Guo; Xiao-Jie Zhang; Shu-Liang Wu; Li-Li Zhong
Journal:  Oncol Lett       Date:  2019-09-03       Impact factor: 2.967

3.  TP53/miR-34a-associated signaling targets SERPINE1 expression in human pancreatic cancer.

Authors:  Shaw M Akula; Peter P Ruvolo; James A McCubrey
Journal:  Aging (Albany NY)       Date:  2020-01-27       Impact factor: 5.682

4.  Bile accelerates carcinogenic processes in pancreatic ductal adenocarcinoma cells through the overexpression of MUC4.

Authors:  Eleonóra Gál; Zoltán Veréb; Lajos Kemény; Dávid Rakk; András Szekeres; Eszter Becskeházi; László Tiszlavicz; Tamás Takács; László Czakó; Péter Hegyi; Viktória Venglovecz
Journal:  Sci Rep       Date:  2020-12-16       Impact factor: 4.379

Review 5.  The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives.

Authors:  Shun Wang; Yan Zheng; Feng Yang; Le Zhu; Xiao-Qiang Zhu; Zhe-Fang Wang; Xiao-Lin Wu; Cheng-Hui Zhou; Jia-Yan Yan; Bei-Yuan Hu; Bo Kong; De-Liang Fu; Christiane Bruns; Yue Zhao; Lun-Xiu Qin; Qiong-Zhu Dong
Journal:  Signal Transduct Target Ther       Date:  2021-07-05

6.  Can Elderly Patients With Pancreatic Cancer Gain Survival Advantages Through More Radical Surgeries? A SEER-Based Analysis.

Authors:  Danna Xie; Baolin Qian; Jing Yang; Xinya Peng; Yinghua Li; Teng Hu; Simin Lu; Xiaojing Chen; Yunwei Han
Journal:  Front Oncol       Date:  2020-10-29       Impact factor: 6.244

7.  LINC00472 suppressed by ZEB1 regulates the miR-23a-3p/FOXO3/BID axis to inhibit the progression of pancreatic cancer.

Authors:  Cong Bi; Gang Wang
Journal:  J Cell Mol Med       Date:  2021-08-07       Impact factor: 5.310
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.